Xuxi Zhang

REFERENCES 1. Zhang, X, Zhao, J, Zhao, T, et al. Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta ‐ analysis of randomized clinical trials. Endocrine 2014;49(1):78 ‐ 89. 2. Crossland, L, Askew, D, Ware, R, et al. Diabetic Retinopathy Screening and Monitoring of Early Stage Disease in Australian General Practice: Tackling Preventable Blindness within a Chronic Care Model. Journal of diabetes research 2016;2016(4):1 ‐ 7. 3. Mohamed, Q, Gillies, MC, Wong, TY. Management of diabetic retinopathy: a systematic review. Jama the Journal of the American Medical Association 2007;298(8):902 ‐ 916. 4. Duckworth, W, Abraira, C, Moritz, T, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes New England Journal of Medicine 2009;360:129 ‐ 130. 5. Azad, N, Bahn, GD, Emanuele, NV, et al. Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT). Diabetes care 2016;39(5):816 ‐ 822. 6. Patel, A, MacMahon, S, Chalmers, J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England journal of medicine 2008;358(24):2560 ‐ 2572. 7. Ohkubo, Y, Kishikawa, H, Araki, E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non ‐ insulin ‐ dependent diabetes mellitus: a randomized prospective 6 ‐ year study. Diabetes research and clinical practice 1995;28(2):103 ‐ 117. 8. Schrier, RW, Estacio, RO, Esler, A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney international 2002;61(3):1086 ‐ 1097. 9. Group, UPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (Clinical research ed) 1998;317(7160):703 ‐ 713. 10. Matthews, DR, Stratton, IM, Aldington, SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Archives of ophthalmology (Chicago, Ill : 1960) 2004;122(11):1631 ‐ 1640. 11. Trento, M, Passera, P, Bajardi, M, et al. Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4 ‐ year randomized controlled clinical trial. Diabetologia 2002;45(9):1231 ‐ 1239. 12. Gaede, P, Vedel, P, Larsen, N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine 2003;348(5):383 ‐ 393. 13. Rachmani, R, Levi, Z, Slavachevski, I, et al. Teaching patients to monitor their risk factors retards the progression of vascular complications in high ‐ risk patients with Type 2 diabetes mellitus ‐‐ a randomized prospective study. Diabetic medicine : a journal of the British Diabetic Association 2002;19(5):385 ‐ 392. 14. Emanuele, N, Klein, R, Abraira, C, et al. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes care 1996;19(12):1375 ‐ 1381. 15. Tovi, J, Ingemansson, SO, Engfeldt, P. Insulin treatment of elderly type 2 diabetic patients: effects on retinopathy. Diabetes & metabolism 1998;24(5):442 ‐ 447. 16. Gaede, P, Vedel, P, Parving, HH, et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (London, England) 1999;353(9153):617 ‐ 622. 17. Pettitt, DJ, Okada Wollitzer, A, Jovanovic, L, et al. Decreasing the risk of diabetic retinopathy in a study of case management: the California Medi ‐ Cal Type 2 Diabetes Study. Diabetes care 2005;28(12):2819 ‐ 2822. 18. Beulens, JW, Patel, A, Vingerling, JR, et al. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia 2009;52(10):2027 ‐ 2036. 19. Chew, EY, Ambrosius, WT, Davis, MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. The New England journal of medicine 2010;363(3):233 ‐ 244. 20. Diaz ‐ Lopez, A, Babio, N, Martinez ‐ Gonzalez, MA, et al. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial. Diabetes care 2015;38(11):2134 ‐ 2141. 21. Action to Control Cardiovascular Risk in Diabetes Follow ‐ On Eye Study, G, the Action to Control Cardiovascular Risk in Diabetes Follow ‐ On Study, G. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow ‐ On Study. Diabetes care 2016;39(7):1089 ‐ 1100. 7 177 Prevention and control of diabetic retinopathy